Home/Filings/4/0001171843-16-010533
4//SEC Filing

PROTEON THERAPEUTICS INC 4

Accession 0001171843-16-010533

$TARACIK 0001359931operating

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 7:49 AM ET

Size

10.5 KB

Accession

0001171843-16-010533

Insider Transaction Report

Form 4
Period: 2016-06-06
Eldridge, George Arthur
Sr VP, CFO, Treasurer & Sec.
Transactions
  • Purchase

    Common Stock

    2016-06-06$5.76/sh+425$2,448425 total(indirect: By Children)
  • Purchase

    Common Stock

    2016-06-06$5.78/sh+400$2,312400 total(indirect: By Children)
  • Purchase

    Common Stock

    2016-06-06$5.78/sh+2,750$15,8952,750 total
  • Purchase

    Common Stock

    2016-06-06$5.78/sh+425$2,455425 total(indirect: By Children)
Footnotes (2)
  • [F1]The purchase price of $5.78 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $5.78 to $5.79. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

Issuer

PROTEON THERAPEUTICS INC

CIK 0001359931

Entity typeoperating

Related Parties

1
  • filerCIK 0001359931

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 7:49 AM ET
Size
10.5 KB